• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏植入式电子设备高能量放电患者心律失常复发的当代管理和预后因素。

Contemporary Management and Prognostic Factors of Arrhythmia Recurrence in Patients with High-Energy Discharge of Cardiac Implantable Electronic Devices.

机构信息

First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, 47 Ziołowa St., 40-635 Katowice, Poland.

出版信息

Medicina (Kaunas). 2024 Oct 10;60(10):1662. doi: 10.3390/medicina60101662.

DOI:10.3390/medicina60101662
PMID:39459449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11509349/
Abstract

: Understanding the underlying causes of implantable cardioverter-defibrillator (ICD) discharges is vital for effective management. This study aimed to evaluate the characteristics of patients admitted following ICD discharge, focusing on myocardial ischemia as a potential exacerbating factor and potential risk factors for VT recurrence. : This retrospective, single-center study included 81 patients with high energy discharge from cardiac implantable electronic device admitted urgently to the cardiology department from 2015 to 2022. The exclusion criterion was ST-segment elevation acute coronary syndrome. Data were collected anonymously from electronic medical records. Patients were categorized based on coronary angiography, percutaneous angioplasty, presence of significant stenosis, recurrent ventricular tachycardia (VT), and catheter ablation. Clinical variables, including demographic data, echocardiographic parameters, and pharmacotherapy, were analyzed. The primary endpoint was the recurrence of VT during in-hospital stay. : Among 81 patients, predominantly male (86.4%), with a mean age of 63.6 years, 55 (67.9%) had coronary artery disease (CAD) as the primary etiology for ICD implantation. Coronary angiography was performed in 34 patients (42.0%) and showed significant stenosis (>50%) in 18 (41.8%) patients, while 8 (26.0%) individuals underwent percutaneous coronary intervention (PCI). Recurrent VT occurred in 21 subjects (26.3%), while ventricular catheter ablation was performed in 36 patients (44.0%). Referral for urgent coronary angiography was associated with presence of diabetes ( = 0.028) and hyperlipidemia ( = 0.022). Logistic regression analysis confirmed NYHA symptomatic class (OR 4.63, = 0.04) and LVH (OR 10.59, = 0.049) were independently associated with relapse of VT. CAD patients underwent catheter ablation more frequently ( = 0.001) than those with dilated cardiomyopathy. : The study showed a low referral rate for coronary angiography among patients with ICD discharge. Presence of LVH and preexisting symptomatic class influence arrhythmia recurrence. Understanding these associations can guide personalized management strategies for ICD recipients.

摘要

了解植入式心脏复律除颤器 (ICD) 放电的根本原因对于有效管理至关重要。本研究旨在评估 ICD 放电后住院患者的特征,重点关注心肌缺血作为潜在的加重因素和 VT 复发的潜在危险因素。

这项回顾性、单中心研究纳入了 2015 年至 2022 年期间因心脏植入式电子设备高能量放电紧急入住心内科的 81 例患者。排除标准为 ST 段抬高型急性冠状动脉综合征。数据匿名从电子病历中收集。根据冠状动脉造影、经皮血管成形术、存在显著狭窄、复发性室性心动过速 (VT) 和导管消融术对患者进行分类。分析临床变量,包括人口统计学数据、超声心动图参数和药物治疗。主要终点是住院期间 VT 的复发。

在 81 例患者中,主要为男性 (86.4%),平均年龄为 63.6 岁,55 例 (67.9%) 因冠状动脉疾病 (CAD) 作为 ICD 植入的主要病因。对 34 例患者进行了冠状动脉造影,其中 18 例 (41.8%) 患者存在显著狭窄 (>50%),8 例 (26.0%) 患者进行了经皮冠状动脉介入治疗 (PCI)。21 例患者出现复发性 VT,36 例患者进行了心室导管消融术 (44.0%)。紧急冠状动脉造影的转诊与糖尿病 ( = 0.028) 和高脂血症 ( = 0.022) 有关。Logistic 回归分析证实 NYHA 症状分级 (OR 4.63, = 0.04) 和 LVH (OR 10.59, = 0.049) 与 VT 复发独立相关。CAD 患者更频繁地接受导管消融术 ( = 0.001),而扩张型心肌病患者则较少。

该研究表明,ICD 放电后患者的冠状动脉造影转诊率较低。LVH 和预先存在的症状分级会影响心律失常的复发。了解这些关联可以为 ICD 接受者的个性化管理策略提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee4/11509349/eef52bb09aae/medicina-60-01662-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee4/11509349/9f3b64c5b88d/medicina-60-01662-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee4/11509349/eef52bb09aae/medicina-60-01662-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee4/11509349/9f3b64c5b88d/medicina-60-01662-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee4/11509349/eef52bb09aae/medicina-60-01662-g002.jpg

相似文献

1
Contemporary Management and Prognostic Factors of Arrhythmia Recurrence in Patients with High-Energy Discharge of Cardiac Implantable Electronic Devices.心脏植入式电子设备高能量放电患者心律失常复发的当代管理和预后因素。
Medicina (Kaunas). 2024 Oct 10;60(10):1662. doi: 10.3390/medicina60101662.
2
Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study.室性心动过速消融中的血液动力学支持:国际 VT 消融中心协作组研究。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1534-1543. doi: 10.1016/j.jacep.2017.07.005. Epub 2017 Nov 15.
3
Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.导致冠心病或非缺血性扩张型心肌病患者 ICD 干预的致室性心律失常的相关因素。
Kardiol Pol. 2012;70(12):1264-75.
4
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.冠心病患者植入除颤器前稳定型室性心动过速的导管消融(VTACH):一项多中心随机对照试验。
Lancet. 2010 Jan 2;375(9708):31-40. doi: 10.1016/S0140-6736(09)61755-4.
5
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.多非利特可降低室性心律失常和植入式心脏复律除颤器治疗的频率。
J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.
6
Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.植入式心律转复除颤器患者电风暴治疗的导管消融:一项前瞻性单中心研究的短期和长期结果
Circulation. 2008 Jan 29;117(4):462-9. doi: 10.1161/CIRCULATIONAHA.106.686534. Epub 2008 Jan 2.
7
Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.缺血性心肌病和植入式除颤器患者的室性心动过速预防或延迟消融(BERLIN VT):一项多中心随机试验。
Circulation. 2020 Mar 31;141(13):1057-1067. doi: 10.1161/CIRCULATIONAHA.119.043400. Epub 2020 Jan 31.
8
Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion.缺血性心肌病和梗死相关冠状动脉慢性完全闭塞患者中预防性基质导管消融对植入式心脏复律除颤器干预的影响。
Europace. 2024 May 2;26(5). doi: 10.1093/europace/euae109.
9
The role of catheter ablation in the management of patients with implantable cardioverter defibrillators presenting with electrical storm.导管消融在植入式心律转复除颤器患者发生电风暴管理中的作用。
Hellenic J Cardiol. 2017 Jan-Feb;58(1):51-56. doi: 10.1016/j.hjc.2017.01.019. Epub 2017 Feb 8.
10
Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.无再同步功能的心脏除颤器植入后患者生存率的决定因素。
Kardiol Pol. 2012;70(11):1099-110.

本文引用的文献

1
Ventricular Tachycardia Due to Triggered Activity: Role of Early and Delayed Afterdepolarizations.室性心动过速与触发活动:早后和迟后除极的作用。
JACC Clin Electrophysiol. 2024 Feb;10(2):379-401. doi: 10.1016/j.jacep.2023.10.033. Epub 2023 Dec 20.
2
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.
3
Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy.
导管消融与升级抗心律失常药物治疗相比,与室性心动过速和 ICD 治疗负担。
JACC Clin Electrophysiol. 2023 Jun;9(6):808-821. doi: 10.1016/j.jacep.2023.01.030. Epub 2023 Mar 22.
4
Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention.用于一级和二级预防的植入式心脏复律除颤器治疗的比较及预测因素
Neth Heart J. 2023 Sep;31(9):348-356. doi: 10.1007/s12471-023-01785-0. Epub 2023 Jun 16.
5
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
6
Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.基于心律失常风险分层和左心室逆重构预测的非缺血性扩张型心肌病患者的一级预防植入型心律转复除颤器的应用。
Heart Fail Rev. 2023 Jan;28(1):229-240. doi: 10.1007/s10741-022-10246-6. Epub 2022 May 19.
7
Arrhythmias in Chronic Kidney Disease.慢性肾脏病中的心律失常
Eur Cardiol. 2022 Mar 7;17:e05. doi: 10.15420/ecr.2021.52. eCollection 2022 Feb.
8
Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.周期性复极动力学可识别非缺血性心肌病患者中的植入式心律转复除颤器(ICD)响应者:一项丹麦子研究
Circulation. 2022 Mar 8;145(10):754-764. doi: 10.1161/CIRCULATIONAHA.121.056464. Epub 2021 Dec 10.
9
Management of implantable cardioverter-defibrillator patients with appropriate ICD shocks: A 3-step treatment concept.对植入式心律转复除颤器患者进行恰当的ICD电击治疗管理:一个三步治疗理念。
Heart Rhythm O2. 2021 Sep 2;2(5):537-540. doi: 10.1016/j.hroo.2021.08.005. eCollection 2021 Oct.
10
Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks.夜间心率与室性快速性心律失常、合适及不合适的植入式心律转复除颤器电击的关联
Front Cardiovasc Med. 2021 Sep 6;8:739889. doi: 10.3389/fcvm.2021.739889. eCollection 2021.